GAM Holding’s Regenxbio RGNX Stock Holding History

GAM Holding’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,894	Closed	-$640K	–	259
2022 Q2	$640K	Hold	25,894	–	–	0.04%	202
2022 Q1	$859K	Hold	25,894	–	–	0.04%	207
2021 Q4	$847K	Hold	25,894	–	–	0.04%	204
2021 Q3	$1.08M	Sell	25,894 -17,332	-40%	-$624K	0.05%	198
2021 Q2	$1.68M	Hold	43,226	–	–	0.07%	199
2021 Q1	$1.47M	Buy	+43,226	New	+$1.84M	0.07%	216
2020 Q4	–	Sell	-135,475	Closed	-$3.73M	–	324
2020 Q3	$3.73M	Buy	135,475 +30,200	+29%	+$985K	0.22%	139
2020 Q2	$3.88M	Hold	105,275	–	–	0.24%	122
2020 Q1	$3.41M	Sell	105,275 -6,300	-6%	-$262K	0.23%	122
2019 Q4	$4.57M	Hold	111,575	–	–	0.22%	140
2019 Q3	$3.97M	Hold	111,575	–	–	0.17%	139
2019 Q2	$5.73M	Hold	111,575	–	–	0.22%	114
2019 Q1	$6.39M	Buy	111,575 +47,675	+75%	+$2.36M	0.27%	97
2018 Q4	$2.68M	Sell	63,900 -7,700	-11%	-$452K	0.14%	175
2018 Q3	$5.41M	Hold	71,600	–	–	0.2%	137
2018 Q2	$5.14M	Hold	71,600	–	–	0.18%	146
2018 Q1	$2.14M	Buy	71,600 +36,400	+103%	+$1.06M	0.08%	274
2017 Q4	$1.17M	Buy	35,200 +18,100	+106%	+$545K	0.04%	533
2017 Q3	$563K	Buy	+17,100	New	+$385K	0.02%	420

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

GAM Holding's RGNX Position: Q3 2022 in Review

GAM Holding sold out of Regenxbio (RGNX) in Q3 2022, closing a stake of 25,894 shares — an estimated $640K sold.

GAM Holding first reported a position in RGNX in Q3 2017 and held it in 19 quarters. The position peaked at $6.39M in Q1 2019. 182 funds tracked by Wall St. Rank hold RGNX as of Q3 2022.

GAM Holding reported no remaining Regenxbio position as of Q3 2022 after selling out during the quarter.
GAM Holding sold 25,894 Regenxbio shares in Q3 2022, an estimated $640K.
GAM Holding first reported a position in Regenxbio in Q3 2017 and held it in 19 quarters.
GAM Holding's Regenxbio position peaked at $6.39M in Q1 2019.
182 funds tracked by Wall St. Rank held Regenxbio as of Q3 2022.

Based on GAM Holding's 13F filing for Q3 2022, filed 19 Oct 2022.